Publications by authors named "Xiao Ling Kuai"

Gastric cancer (GC) is a leading cause of cancer‑associated mortality worldwide. Previous studies demonstrated that long noncoding RNAs (lncRNAs) may be dysregulated in GC and may serve important roles in cancer progression. The present study aimed to investigate the role of the novel lncRNA stomach cancer‑associated transcript 16 (STCAT16; Assembly Gene ID G038291) in the development and progression of GC.

View Article and Find Full Text PDF

The molecular mechanism of bone marrow mesenchymal stromal stem cells (BMSCs) mobilization and migration to the liver was poorly understood. Stromal cell-derived factor-1 (SDF-1) participates in BMSCs homing and migration into injury organs. We try to investigate the role of SDF-1 signaling in BMSCs migration towards injured liver.

View Article and Find Full Text PDF

Introduction: Globoid cell leukodystrophy (GLD) is a severe disorder of the central and peripheral nervous system caused by the absence of galactocerebrosidase (GALC) activity. Cell-based therapies are highly promising strategies for GLD. In this study, G-Olig2 mouse embryonic stem cells (ESCs) were induced into oligodendrocyte progenitor cells (OPCs) and were implanted into the brains of twitcher mice, an animal model of GLD, to explore the therapeutic potential of the cells.

View Article and Find Full Text PDF

Objective: To investigate whether cells derived from rhesus monkey embryonic stem cells (ESC) had hepatocyte characteristics after the differentiation.

Methods: Rhesus monkey ESC were induced towards hepatocyte-like cells via a four-step differentiation process: the formation of embryoid bodies (EB), EB in activin A and insulin-transferrin-selenium medium for 4 days, in fibroblast growth factor (FGF)-4 and bone morphogenetic protein-2 (BMP2) medium for 8 days, in hepatocyte culture medium containing hepatocyte growth factor for 3 days and then with oncostatin M and dexamethasone for another 5 days. Expression of albumin (ALB), glucose-6-phosphatase, α-fetoprotein (AFP) and α-1 antitrypsin (α1-AT) at the mRNA level in differentiated cells were detected by reverse transcription-polymerase chain reaction.

View Article and Find Full Text PDF

Aim: The impact of viral status on recurrence of hepatitis B-related hepatocellular carcinoma (HCC) after curative therapy remains controversial. This meta-analysis aimed to determine whether the presence of viral load, genotype, specific mutation and antiviral therapy influenced HCC recurrence after curative therapy.

Methods: We performed a meta-analysis including 20 studies to assess the effect of viral status and antiviral therapy with nucleoside analog on recurrence of HCC after curative therapy.

View Article and Find Full Text PDF
Article Synopsis
  • 5-aza-2'-deoxycytidine (5-aza-CdR) is an anticancer drug that can reactivate the tumor suppressor gene CDX2 in gastric cancer, leading to improved survival rates in patients expressing CDX2.
  • In gastric cancer tissues, higher levels of DNA methyltransferase 1 (DNMT1) correlate with advanced disease features, while CDX2 expression is inversely related to DNMT1, suggesting that DNMT1 silences CDX2.
  • Treatment with 5-aza-CdR demethylates the CDX2 promoter, increases its expression, reduces DNMT1 levels, and leads to inhibited cell growth and increased apoptosis in gastric cancer cell
View Article and Find Full Text PDF
Article Synopsis
  • A meta-analysis evaluated whether interferon (IFN) therapy lowers the risk of hepatocellular carcinoma (HCC) in patients with hepatitis C (HCV)-related cirrhosis, finding significant reductions in HCC incidence.
  • The study included eight randomized controlled trials with over 1500 patients, showing that IFN therapy reduced overall HCC incidence in the short term and the effect became more pronounced with long-term follow-ups (over 48 months).
  • Additionally, patients who did not achieve sustained virological response from initial IFN treatment benefitted from maintenance IFN therapy, resulting in a lower HCC risk compared to those who did not receive this treatment.
View Article and Find Full Text PDF

The differentiation of embryonic stem cells (ESCs) into neurons and glial cells represents a promising cell-based therapy for neurodegenerative diseases. Because the rhesus macaque is physiologically and phylogenetically similar to humans, it is a clinically relevant animal model for ESC research. In this study, the pluripotency and neural differentiation potential of a rhesus monkey ESC line (ORMES6) was investigated.

View Article and Find Full Text PDF

Objective: Tissue-specific stem cells from differentiating embryonic stem (ES) cells are both pluripotent and genetically flexible. Recent observations indicate that ES cells can differentiate into hepatocytes. Therefore, cell-based therapy can potentially be a therapeutic alternative to liver transplantation.

View Article and Find Full Text PDF

Background & Objective: Serum fast band of glycylproline dipeptidyl aminopeptidase isoenzyme (GPDA-F) is useful to the diagnosis of hepatocellular carcinoma, especially for the cases without expression of alpha-fetoprotein (AFP). Polyacrylamide electrophoresis for detection of GPDA-F is relatively complicated and has limitation in its clinical use. This study was to establish a simple and easy method of immunoelectrophoresis to detect serum GPDA-F, and evaluate clinical value of GPDA-F in the diagnosis of hepatocelluar carcinoma.

View Article and Find Full Text PDF

Embryonic stem (ES) cells are pluripotent cells derived from the inner cell mass of fertilized blastocysts in vitro. ES cells can be induced to undergo differentiation into potentially all cell types. The aim of this study is to examine the differentiating potential of mouse ES cells into hepatocytes in the presence of retinoic acid (RA), hepatocyte growth factor (HGF), and beta-nerve growth factor (beta-NGF).

View Article and Find Full Text PDF